Huihui Hu

Also affiliated with Capital Medical University, Zhengzhou University, Soochow University, Jining First People's Hospital, Women's Hospital, School of Medicine, Zhejiang University, Henan Cancer Hospital, Jiangsu Hengrui Medicine (China), Anyang Tumor Hospital, Southeast University, Northwest A&F University

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Preclinical studies of the triazolo[1,5-a]pyrimidine derivative WS-716 as a highly potent, specific and orally active P-glycoprotein (P-gp) inhibitor”.

Preclinical studies of the triazolo[1,5-a]pyrimidine derivative WS-716 as a highly potent, specific and orally active P-glycoprotein (P-gp) inhibitor

Acta Pharmaceutica Sinica B(2022)10.1016/j.apsb.2022.03.023

N/A

0.542DataRank · unranked

36 citations

Qiu‐Xu Teng, Shuai Wang, Zi‐Ning Lei, Huihui Hu, Huifang Lv +9 more